10. Focused scenario bank
Self-contained overlay scenarios — written so a nurse who does not know the patient can act on them. Each states the actual finding and the objective reference (the ordered parameter, a measured value, or the documented plan), not “at baseline.” Edit to the actual visit and orders; do not copy.
S1 Pain at the functional goal, safety vitals within limits | Pain-management overlay to the Pain assessment. Pain is 4/10 and, more importantly, the patient can transfer and sleep, meeting the ordered functional goal; the sedation score is at the alert end of the ordered scale and the respiratory rate is 16, above the <10 threshold, assessed after the last opioid dose. Naloxone is present and not expired. Pain controlled to the functional goal with safety vitals within limits, measured against the orders, confirms safe, effective control this visit; safe use, naloxone, and over-sedation recognition were reinforced, with the caregiver return-demonstrating naloxone correctly. |
|---|---|
S2 Uncontrolled pain above the functional goal | Pain-management overlay finding pain of 8/10 that prevents the patient from transferring or sleeping — above the ordered functional goal despite adherence to the regimen — with breakthrough use at the ordered limit and safety vitals within range (respiratory rate 16, alert). The provider was notified at 10:30 with the functional impact and breakthrough frequency; orders to adjust the regimen were received and taught. Non-pharmacologic measures were reinforced, and pain against the functional goal will be reassessed next visit. |
S3 Over-sedation with falling respiratory rate | Pain-management overlay finding the patient difficult to rouse with a respiratory rate of 9 — increasing sedation with a respiratory rate below the <10 threshold — shortly after an opioid dose. The next opioid dose was held per the safety parameters; the patient was stimulated and positioned to support breathing and monitored closely; the provider was notified urgently at 13:10 and a dose reduction ordered. Naloxone was kept at hand; sedation and respiratory rate were monitored until they returned to a safe range. |
S4 Opioid-induced respiratory depression | Pain-management overlay finding the patient unarousable with a respiratory rate of 6 and pinpoint pupils — opioid-induced respiratory depression. Naloxone was administered per order without delay and EMS activated; the airway and breathing were supported and the response to naloxone monitored, with a repeat dose readied per order. The provider was notified at 14:45; respiratory rate and responsiveness were monitored continuously pending transport. |
S5 Naloxone readiness gap | Pain-management overlay finding the patient on scheduled opioids but with an expired naloxone kit and a caregiver unsure of its use — a safety gap. The provider was notified at 09:50 and a replacement obtained; the caregiver was taught and return-demonstrated correct naloxone administration and to call EMS immediately after. The restored, in-date naloxone and the caregiver’s competence close the gap; readiness will be reconfirmed next visit. |
S6 Opioid-induced constipation | Pain-management overlay finding no bowel movement for four days on scheduled opioids, exceeding the ordered three-day interval, with mild abdominal discomfort but no distension or vomiting — opioid-induced constipation. The provider was notified at 11:20; orders to intensify the bowel regimen were received and taught. Hydration, activity, and the bowel regimen were reinforced, and bowel status will be reassessed next visit; obstruction warning signs were reviewed (cross-reference Gastrointestinal). |
S7 Concurrent CNS depressant identified | Pain-management overlay identifying that the patient had resumed alcohol use in the evenings while on opioids — a combination that raises the respiratory-depression risk. The finding was addressed supportively as a safety issue and the provider notified at 15:05; the risk and the safety plan were discussed. The patient was taught the danger of combining opioids with alcohol or sedatives, and the safety vitals will be monitored closely; the situation will be reassessed. |
S8 Safe-use teaching mastered | Pain-management overlay documenting that the patient and caregiver, taught over prior visits, correctly demonstrated safe storage away from others, proper disposal, naloxone use, and the recognition of over-sedation. The demonstrated competence in the safety measures confirms the teaching is effective; the plan was reinforced and naloxone readiness confirmed, with the safety vitals within limits (respiratory rate 16, alert). |
S9 Function improved on a stable regimen | Pain-management overlay documenting that pain is 3/10 with the patient now able to participate in therapy and sleep through the night — meeting the ordered functional goal — on a stable regimen, with safety vitals within limits and a bowel movement every one to two days within the ordered interval. Pain controlled to the functional goal with the safety and bowel parameters within limits, measured against the orders, confirms the plan is working; safe use, naloxone, and the bowel regimen were reinforced, and the functional gains documented. |